Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Vivmark Residential Common Shares of Beneficial Interest (VMRK) Price & Performance

Royalty Pharma plc Class A Ordinary SharesTrade
Vivmark Residential Common Shares of Beneficial InterestTrade

Price performance (Past 24H)

Key statistics

Royalty Pharma plc Class A Ordinary Shares vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B), while Vivmark Residential Common Shares of Beneficial Interest trades at $61.11 (market cap $46.41B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is the larger of the two by market cap, and Vivmark Residential Common Shares of Beneficial Interest pays the higher dividend (4.68%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and Vivmark Residential Common Shares of Beneficial Interest for 1 Days on average.

RPRXVMRK
Market Cap
$25.27B$46.41B
Volume
3,671,1836,584,008
Sector
HealthReal Estate
52-Week High
$63.96$70.15
52-Week Low
$35.44$57.98
Typical Hold Time
1 Days1 Days
Enterprise Value
$32.50B$55.52B
Dividend Yield
1.66%4.68%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →

About Vivmark Residential Common Shares of Beneficial Interest

Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.

Read more on VMRK →